5-噻唑甲酸甲酯 | 14527-44-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 中文名称: 5-噻唑甲酸甲酯
• 中文别名: 噻唑-5-羧酸甲酯；噻唑-5-甲酸甲酯;；噻唑-5-甲酸甲酯
• 英文名称: methyl thiazole-5-carboxylate
• 英文别名: methyl 1,3-thiazole-5-carboxylate
• CAS: 14527-44-7
• 化学式: C₅H₅NO₂S
• mdl: MFCD03788563
• 分子量: 143.166
• InChiKey: XDIBWBYTRTUUBJ-UHFFFAOYSA-N

物化性质

• 熔点：
  68-69°C
• 沸点：
  87-90°C (10 mmHg)
• 密度：
  1.45

计算性质

• 辛醇/水分配系数(LogP)：
  1.1
• 重原子数：
  9
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.2
• 拓扑面积：
  67.4
• 氢给体数：
  0
• 氢受体数：
  4

安全信息

• 危险品标志：
  Xn
• 危险类别码：
  R36/37/38
• 海关编码：
  2934100090
• 安全说明：
  S26
• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H335
• 储存条件：
  室温

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: Methyl thiazole-5-carboxylate
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: Methyl thiazole-5-carboxylate
CAS number: 14527-44-7

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C5H5NO2S
Molecular weight: 143.2

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, sulfur oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  5-噻唑甲酸甲酯 在 sodium hydroxide 作用下， 以 四氢呋喃 、 乙醚 、 水 为溶剂， 生成 5-羟甲基噻唑
  参考文献：
  名称：

  .alpha.- and .beta.-amino acid hydroxyethylamino sulfonamides useful as

  摘要：

  .alpha.-和.beta.-氨基酸羟乙基氨基磺酰胺化合物作为逆转录病毒蛋白酶抑制剂具有有效性，特别是作为HIV蛋白酶的抑制剂。

  公开号：

  US05968942A1
• 作为产物：
  描述：

  2-氨基噻唑-5-甲酸甲酯 在 亚硝酸异戊酯 作用下， 以 四氢呋喃 为溶剂， 反应 0.33h， 以88%的产率得到5-噻唑甲酸甲酯
  参考文献：
  名称：

  芳香杂环的流动加氢重氮

  摘要：

  连续流动加工用于用氢化物快速取代芳族氨基。该方法应用于一系列芳香杂环，证实了该过程的广泛范围和取代基耐受性。使用流动设备并优化工艺以克服在先前依赖批处理程序的研究中限制产率的有问题的不稳定中间体。研究了各种常见的有机溶剂作为潜在的氢化物来源。该方法允许使用纯有机可溶系统以良好的产率对关键结构（例如氨基吡唑和氨基吡啶）进行脱氨基。

  DOI：

  10.3390/molecules24101996

文献信息

• 5-噻唑酰胺类化合物及生物学应用
  申请人：中山大学肿瘤防治中心

  公开号：CN101921268B

  公开（公告）日：2016-08-03

  本发明涉及一种5?噻唑酰胺类化合物及生物学应用，其结构式为本发明提供了由通式(I)表示的靶向AKT/PKB激酶(ATP结合位点)的5?噻唑酰胺类化合物。实验证明，本发明所涉及的噻唑酰胺类AKT抑制剂能在体外显著抑制AKT激酶的活性，并对多种AKT活性高的肿瘤细胞株具有很强的增殖抑制作用，表明噻唑酰胺类化合物可用于制备抗肿瘤药物。
• Ag–Cu copromoted direct C2–H bond thiolation of azoles with Bunte salts as sulfur sources
  作者：Rui Wang、Hongyan Xu、Ying Zhang、Yuntao Hu、Yingsu Wei、Xiao Du、Huaiqing Zhao

  DOI：10.1039/d1ob00823d

  日期：——

  A direct C2–H thiolation of azoles with Bunte salts was achieved under the combined action of copper and silver salts, furnishing various substituted 2-thioazoles in moderate to good yields.

  使用铜盐和银盐的共同作用，实现了与Bunte盐的直接C2-H硫化作用，在中等到良好的产率下提供了各种取代的2-硫代咪唑。
• Substituted phenylimidazopyrazoles and their use
  申请人：BAYER INTELLECTUAL PROPERTY GmbH

  公开号：US20130190290A1

  公开（公告）日：2013-07-25

  The present application relates to novel 1-phenyl-1H-imidazo[1,2-b]pyrazole derivatives, to processes for their preparation, to their use for the treatment and/or prevention of diseases and to their use for preparing medicaments for the treatment and/or prevention of diseases, in particular angiogenic disorders and hyperproliferative disorders, where neovascularization plays a role, such as, for example, neoplastic disorders and tumour disorders. Such treatments can be carried out as monotherapy or else in combination with other medicaments or further therapeutic measures.

  本申请涉及新颖的1-苯基-1H-咪唑[1,2-b]吡唑衍生物，其制备方法，其用于治疗和/或预防疾病以及用于制备用于治疗和/或预防疾病的药物，特别是血管生成障碍和过度增殖障碍，其中血管新生起到作用，例如肿瘤性疾病和肿瘤性疾病。这种治疗可以作为单独治疗，也可以与其他药物或其他治疗措施结合使用。
• Visible-Light Photoredox Decarboxylation of Perfluoroarene Iodine(III) Trifluoroacetates for C–H Trifluoromethylation of (Hetero)arenes
  作者：Bin Yang、Donghai Yu、Xiu-Hua Xu、Feng-Ling Qing

  DOI：10.1021/acscatal.7b03990

  日期：2018.4.6

  trifluoromethylation of (hetero)arenes with easily accessible C6F5I(OCOCF3)2 under photoredox catalysis has been developed. This method is tolerant of various (hetero)arenes and functional groups. Notably, C6F5I is recycled from the decarboxylation reaction and further used for the preparation of C6F5I(OCOCF3)2. The combination of photoredox catalysis and hypervalent iodine reagent provides a practical approach

  已经开发了在光氧化还原催化下具有易于获得的C 6 F 5 I（OCOCF 3）2的可扩展且操作简单的（杂）芳烃的脱羧三氟甲基化。该方法可耐受各种（杂）芳烃和官能团。值得注意的是，C 6 F 5 I从脱羧反应中再循环并进一步用于制备C 6 F 5 I（OCOCF 3）2。光氧化还原催化和高价碘试剂的结合为三氟乙酸在三氟甲基化反应中的应用提供了一种实用的方法。
• PYRROLIDINONE DERIVATIVES AS GPR119 MODULATORS FOR THE TREATMENT OF DIABETES, OBESITY, DYSLIPIDEMIA AND RELATED DISORDERS
  申请人：SCHWINK Lothar

  公开号：US20140099333A1

  公开（公告）日：2014-04-10

  The present invention relates to pyrrolidinone derivatives. The pyrrolidinone derivatives are GPR119 modulators and useful for the prevention and/or treatment of diabetes, obesity, dyslipidemia and related disorders. The invention furthermore relates to the use of pyrrolidinone derivatives as active ingredients in pharmaceuticals, and pharmaceutical compositions comprising them.

  本发明涉及吡咯烷酮衍生物。这些吡咯烷酮衍生物是GPR119调节剂，适用于预防和/或治疗糖尿病、肥胖、血脂异常及相关疾病。此外，本发明还涉及将吡咯烷酮衍生物用作药物中的活性成分，以及包含它们的药物组合物。